Incarceration experiences in a cohort of active injection drug users

References

• Kerr T, Wood E, Grafstein E, et al. High rates of primary care and emergency department use among injection drug users in Vancouver. J Public Health (Oxf) 2005; 27: 62–66
   PubMed Web of Science ®Google Scholar
• Spittal P M, Hogg R S, Li K, et al. Drastic elevations in mortality among female injection drug users in a Canadian setting. AIDS Care 2006; 18: 101–108
   PubMed Web of Science ®Google Scholar
• Strathdee S A, Patrick D M, Currie S L, et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. Aids 1997; 11: F59–F65
   PubMed Web of Science ®Google Scholar
• Thomas K. Female injection drug users in Vancouver face higher risks of HIV infection. Can HIV AIDS Policy Law Rev 2002; 7: 36
   PubMedGoogle Scholar
• Beyrer C, Jittiwutikarn J, Teokul W, et al. Drug use, increasing incarceration rates, and prison-associated HIV risks in Thailand. AIDS Behav 2003; 7: 153–161
   PubMed Web of Science ®Google Scholar
• Clarke J G, Stein M D, Hanna L, Sobota M, Rich J D. Active and former injection drug users report of HIV risk behaviors during periods of incarceration. Subst Abuse 2001; 22: 209–216
   PubMedGoogle Scholar
• Lopez-Zetina J, Kerndt P, Ford W, Woerhle T, Weber M. Prevalence of HIV and hepatitis B and self-reported injection risk behavior during detention among street-recruited injection drug users in Los Angeles County, 1994 – 1996. Addiction 2001; 96: 589–595
   PubMed Web of Science ®Google Scholar
• Pallas J R, Farinas-Alvarez C, Prieto D, Delgado-Rodriguez M. Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users. Eur J Epidemiol 1999; 15: 699–704
   PubMed Web of Science ®Google Scholar
• Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry J V. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: Results of a national cross sectional survey. BMJ 2000; 8 321: 78–82
   PubMedGoogle Scholar
• Malliori M, Sypsa V, Psichogiou M, et al. A survey of blood-borne viruses and associated risk behaviours in Greek prisons. Addiction 1998; 93: 243–251
   PubMed Web of Science ®Google Scholar
• Shewan D, Gemmell M, Davies J B. Behavioural change amongst drug injectors in Scottish prisons. Soc Sci Med 1994; 39: 1585–1586
   PubMed Web of Science ®Google Scholar
• Darke S, Kaye S, Finlay-Jones E. Drug use and injection risk-taking among prison methadone maintenance patients. Addiction 1998; 93: 1169–1175
   PubMed Web of Science ®Google Scholar
• Small W, Kain S, Laliberte N, Schechter M T, O'Shaughnessy M V, Spittal P M. Incarceration, addiction and harm reduction: Inmates experience injecting drugs in prison. Subst Use Misuse 2005; 40: 831–843
   PubMed Web of Science ®Google Scholar
• Calzavara L M, Burchell A N, Schlossberg J, et al. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction 2003; 98: 1257–1265
   PubMed Web of Science ®Google Scholar
• Choopanya K, Des Jarlais D C, Vanichseni S, et al. Incarceration and risk for HIV infection among injection drug users in Bangkok. J Acquir Immune Defic Syndr 2002; 29: 86–94
   PubMed Web of Science ®Google Scholar
• Rotily M, Weilandt C, Bird S M, et al. Surveillance of HIV infection and related risk behaviour in European prisons. A multicentre pilot study. Eur J Public Health 2001; 11: 243–250
   PubMed Web of Science ®Google Scholar
• Strang J, Gossop M, Heuston J, Green J, Whiteley C, Maden A. Persistence of drug use during imprisonment: relationship of drug type, recency of use and severity of dependence to use of heroin, cocaine and amphetamine in prison. Addiction 2006; 101: 1125–1132
   PubMed Web of Science ®Google Scholar
• Dolan K. The epidemiology of hepatitis C infection in prison populations. Commonwealth Department of Health and Aged Care. Hepatitis C: Informing Australia's national response. Commonwealth Department of Health and Aged Care, Canberra 2000; 61–93
   Google Scholar
• Koulierakis G, Gnardellis C, Agrafiotis D, Power K G. HIV risk behaviour correlates among injecting drug users in Greek prisons. Addiction 2000; 95: 1207–1216
   PubMed Web of Science ®Google Scholar
• Hankins C A, Gendron S, Handley M A, Richard C, Tung M T, O'Shaughnessy M. HIV infection among women in prison: An assessment of risk factors using a nonnominal methodology. Am J Public Health 1994; 84: 1637–1640
   PubMed Web of Science ®Google Scholar
• Jurgens R. HIV/AIDS in prisons: New developments. Canadian HIV/AIDS Policy Law Newslett 1999; 4: 61–66
   Google Scholar
• Ford P M, Pearson M, Sankar-Mistry P, Stevenson T, Bell D, Austin J. HIV, hepatitis C and risk behaviour in a Canadian medium-security federal penitentiary. Queen's University HIV Prison Study Group. Q J Med 2000; 93: 113–119
   Google Scholar
• Macalino G E, Vlahov D, Sanford-Colby S, et al. Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health 2004; 94: 1218–1223
   PubMed Web of Science ®Google Scholar
• Weild A R, Gill O N, Bennett D, Livingstone S J, Parry J V, Curran L. Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: A national survey. Commun Dis Public Health 2000; 3: 121–126
   PubMedGoogle Scholar
• Beyrer C. HIV epidemiology update and transmission factors: Risks and risk contexts, XVI International AIDS Conference, Toronto, Canada, 14 August 2006
   Google Scholar
• Correctional Services Canada. Infection disease prevention and control in Canadian federal penitentiaries. The Government of Canada, Ottawa 2003
   Google Scholar
• Millson P, Myers T, Rankin J, et al. Prevalence of human immunodeficiency virus and associated risk behaviour in injection drug users in Toronto. Can J Public Health 1995; 86: 176–180
   PubMed Web of Science ®Google Scholar
• Mahon N. New York inmates’ HIV risk behaviors: The implications for prevention policy and programs. Am J Public Health 1996; 86: 1211–1215
   PubMed Web of Science ®Google Scholar
• Correctional Service of Canada (CSC). Correctional Service of Canada (CSC) action plan in response to the report of the Canadian Human Rights Commission. The Government of Canada, Ottawa 2005
   Google Scholar
• Correctional Services Canada. Response from the Correctional Service of Canada to the 33rd Annual Report of the Correctional Investigator (2005 – 2006). The Government of Canada, Ottawa 2006
   Google Scholar
• Kondro W. Conservative government scuttles needle exchange. Can Med Assoc J 2007; 176: 308
   Google Scholar
• The attorney-general of Canada. National anti drug strategy: Backgrounder. The Government of Canada, Ottawa 2007
   Google Scholar
• Tyndall M W, Currie S, Spittal P, et al. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic. Aids 2003; 17: 887–893
   PubMed Web of Science ®Google Scholar
• Hagan H. The relevance of attributable risk measures to HIV prevention planning. Aids 2003; 17: 911–913
   PubMedGoogle Scholar
• Kerr T, Wood E, Small D, Palepu A, Tyndall M W. Potential use of safer injecting facilities among injection drug users in Vancouver's Downtown Eastside. Can Med Assoc J 2003; 169: 759–763
   PubMed Web of Science ®Google Scholar
• Wood E, Kerr T, Buchner C, Marsh D, Montaner J, Tyndall M. Methodology for evaluating Insite: Canada's first medically supervised safer injection facility for injection drug users. Harm Reduct J 2004; 1: 9
   PubMedGoogle Scholar
• Tyndall M W, Kerr T, Zhang R, King E, Montaner J G, Wood E. Attendance, drug use patterns, and referrals made from North America's first supervised injection facility. Drug Alcohol Depend 2006; 83: 193–198
   PubMed Web of Science ®Google Scholar
• Kerr T, Fairbairn N, Tyndall M W, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend 2007; 39–45
   PubMedGoogle Scholar
• Wood E, Li K, Small W, Montaner J S, Schechter M T, Kerr T. Recent incarceration independently associated with syringe sharing by injection drug users (Washington, DC: 1974). Public Health Rep 2005; 150–156
   PubMedGoogle Scholar
• Calzavara L M, Burchell A N, Schlossberg J, et al. Prior opiate injection and incarceration history predict injection drug use among inmates. Addiction 2003; 1257–1265
   PubMedGoogle Scholar
• Wood E, Tyndall M W, Spittal P A, et al. Unsafe injection practices in a cohort of injection drug users in Vancouver: Could safer injecting rooms help?. Can Med Assoc J 2001; 165: 405–410
   PubMed Web of Science ®Google Scholar
• Lee J H, Herzog T A, Meade C D, Webb M S, Brandon T H. The use of GEE for analyzing longitudinal binomial data: a primer using data from a tobacco intervention. Addict Behav 2007; 32: 187–193
   PubMed Web of Science ®Google Scholar
• Shah N G, Galai N, Celentano D D, Vlahov D, Strathdee S A. Longitudinal predictors of injection cessation and subsequent relapse among a cohort of injection drug users in Baltimore, MD, 1988 – 2000. Drug Alcohol Depend 2006; 83: 147–156
   PubMed Web of Science ®Google Scholar
• Boe R, Nafekh M, Vuong B, Sinclair R, Cousineau C. The changing profile of the Federal inmate population: 1997 to 2002. The Government of Canada, Ottawa 2003
   Google Scholar
• Aboriginal Issues Branch, Correctional Services of Canada. Demographic overview of Aboriginal peoples in Canada and Aboriginal offenders in Federal corrections. The Government of Canada, Ottawa 1999
   Google Scholar
• Dufour A, Alary M, Poulin C, et al. Prevalence and risk behaviours for HIV infection among inmates of a provincial prison in Quebec City. Aids 1996; 10: 1009–1015
   PubMed Web of Science ®Google Scholar
• Hall J, et al. A breeding ground for communicable disease; needle exchange program urged; HIV affects 2% of adult inmates. Toronto Star 16 August, 2006, Sect. 6
   Google Scholar
• Kerr T, Tyndall M, Li K, Montaner J, Wood E. Safer injection facility use and syringe sharing in injection drug users. Lancet 2005; 366: 316–318
   PubMed Web of Science ®Google Scholar
• United Nations General Assembly. High Commissioner for Human Rights, Basic principles for the treatment of prisoners. Office of the United Nations, Geneva 1990
   Google Scholar
• The Parliament of Canada. Corrections and Conditional Release Act. C-44. The Parliament of Canada, Non-Medical Uses of Drugs, Ottawa 1992
   Google Scholar
• House of Commons Special Committee on Policy for the new millennium: Working together to redefine Canada's drug strategy. The Parliament of Canada, Ottawa 2002
   Google Scholar
• Canadian Human Rights Commission. Protecting their rights: A systemic review of human rights in correctional services for federally sentenced women. The Parliament of Canada, Ottawa 2003
   Google Scholar
• House of Commons Standing Committee on Health. Strengthening the Canadian strategy on HIV/AIDS. The Parliament of Canada, Ottawa 2003
   Google Scholar
• Ontario Medical Association. Improving our health: Why is Canada lagging behind in establishing needle exchange programs in prison?. Ontario Medical Association, Toronto, Ontario 2004
   Google Scholar
• Correctional Investigator of Canada. Annual report. The Parliament of Canada, Ottawa 2006
   Google Scholar
• Kerr T, Wood E, Betteridge G, Lines R, Jürgens R. Harm reduction in prisons: A ‘rights based analysis'. Crit Public Health 2004; 14: 345–360
   Google Scholar
• Lines R, Jürgens R, Betteridge G, Stöver H, Laticevschi D, Nelles J. Prison needle exchange: Lessons from a comprehensive review of international evidence and experience. Canadian HIV/AIDS Legal Network, Montreal, Quebec 2006
   Google Scholar
• Dolan K, Rutter S, Wodak A. Prison-based syringe-exchange programmes: A review of international research and development. Addiction 2003; 98: 153–158
   PubMed Web of Science ®Google Scholar
• Wong T, Archibald C, Arthur J, et al. Prison needle exchange: Review of the evidence. Public Health Agency of Canada, Ottawa 2006
   Google Scholar
• Wood E, Li K, Small W, Montaner J S, Schechter M T, Kerr T. Recent incarceration independently associated with syringe sharing by injection drug users. Public Health Rep 2005; 120: 150–156
   PubMed Web of Science ®Google Scholar
• Tyndall M W, Wood E, Zhang R, Lai C, Montaner J S, Kerr T. HIV seroprevalence among participants at a Supervised Injection Facility in Vancouver, Canada: Implications for prevention, care and treatment. Harm Reduct J 2006; 3: 36
   PubMedGoogle Scholar
• Des Jarlais D C, Paone D, Milliken J, et al. Audio-computer interviewing to measure risk behaviour for HIV among injecting drug users: A quasi-randomised trial. Lancet 1999; 353: 1657–1661
   PubMed Web of Science ®Google Scholar